Moleculin Biotech MBRX

$ 2.84 6.37%

Quarterly report 2024-Q3
added 11-08-2024

Moleculin Biotech Financial Statements 2011-2024 | MBRX

Annual Financial Statements Moleculin Biotech

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	11.5 M	1.93 M	37.4 M	49 M	36 M	35.5 M	35.7 M	18.4 M	-	-	-	-	-
Shares	1.98 M	1.91 M	26.9 M	9.85 M	6.79 M	4.32 M	3.09 M	1.64 M	-	-	-	-	-
Historical Prices	5.8	1.01	1.39	4.23	4.03	7.98	11.9	6.84	-	-	-	-	-
Net Income	-29.8 M	-29 M	-15.9 M	-17.4 M	-13.2 M	-11.9 M	-9.8 M	-3.93 M	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-29.6 M	-30.6 M	-23 M	-19.7 M	-17.5 M	-15 M	-8.65 M	-3.88 M	-	-	-	-	-
Interest Expense	48 K	40 K	40 K	28 K	15 K	-40 K	-	43.2 K	-	-	-	-	-
EBITDA	-29.5 M	-30.5 M	-22.8 M	-21.9 M	-17.3 M	-15 M	-8.64 M	-3.88 M	-	-	-	-	-
Operating Expenses	29.6 M	30.6 M	23 M	19.7 M	17.5 M	15 M	8.65 M	3.88 M	-	-	-	-	-
General and Administrative Expenses	10 M	11.5 M	8.39 M	6.78 M	6.31 M	5.23 M	4.09 M	2.38 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Moleculin Biotech

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	3.71 M	2.54 M	2.23 M	1.99 M	1.98 M	28.7 M	28.6 M	28.6 M	28.6 M	28.6 M	28.6 M	28.6 M	28.5 M	21.8 M	11.5 M	10.2 M	9.91 M	8.32 M	7.62 M	45.5 M	42.4 M	29.1 M	28.5 M	26.9 M	25.9 M	23.3 M	21.5 M	20.5 M	17.9 M	14.6 M	12.2 M	11.6 M	8.88 M	6.72 M	6.66 M	4.32 M	6.66 M	6.66 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-10.6 M	-4.32 M	-	-5.61 M	-5.98 M	-7.92 M	-	-8.61 M	-6.78 M	-6.87 M	-	-4.38 M	-4.24 M	-4.44 M	-	-3.4 M	-10.1 M	-1.21 M	-	-4.14 M	-1.22 M	-4.04 M	-	-2.04 M	-5.12 M	-1.93 M	-	-2.87 M	-3.42 M	-329 K	-	-1.43 M	-739 K	-332 K	-	-224 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-7.14 M	-6.18 M	-	-5.95 M	-6.41 M	-8.35 M	-	-9.08 M	-7.43 M	-7.07 M	-	-6.16 M	-5.52 M	-6.09 M	-	-6.15 M	-5.03 M	-5.06 M	-	-4.51 M	-3.63 M	-4.57 M	-	-2.59 M	-5.46 M	-2.64 M	-	-2.4 M	-1.32 M	-1.54 M	-	-1.42 M	-724 K	-321 K	-	-223 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	9 K	11 K	-	13 K	9 K	8 K	-	19 K	15 K	5 K	-	13 K	8 K	9 K	-	10 K	17 K	5 K	-	5 K	-	-	-	-21 K	-1 K	1 K	-	1 K	-	1 K	-	10 K	15 K	11 K	-	1.56 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-7.1 M	-6.15 M	-	-5.92 M	-6.38 M	-8.32 M	-	-9.05 M	-7.4 M	-7.04 M	-	-6.12 M	-5.47 M	-6.04 M	-	-6.09 M	-4.98 M	-5.02 M	-	-4.46 M	-3.58 M	-4.52 M	-	-2.58 M	-5.45 M	-2.63 M	-	-2.4 M	-1.32 M	-1.53 M	-	-1.42 M	-723 K	-321 K	-	-223 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	7.14 M	6.18 M	-	5.95 M	6.41 M	8.35 M	-	9.08 M	7.43 M	7.07 M	-	6.16 M	5.52 M	6.09 M	-	6.15 M	5.03 M	5.06 M	-	4.51 M	3.63 M	4.57 M	-	2.59 M	5.46 M	2.64 M	-	2.4 M	1.32 M	1.54 M	-	1.42 M	724 K	321 K	-	223 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.17 M	2.06 M	-	2.64 M	2.49 M	2.64 M	-	3.09 M	3.2 M	2.42 M	-	2.02 M	2.43 M	1.94 M	-	1.66 M	1.65 M	1.81 M	-	1.67 M	1.48 M	1.59 M	-	1.25 M	1.22 M	1.39 M	-	1.34 M	800 K	848 K	-	924 K	618 K	306 K	-	184 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency